BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34264440)

  • 1. Ensemble learning application to discover new trypanothione synthetase inhibitors.
    Alice JI; Bellera CL; Benítez D; Comini MA; Duchowicz PR; Talevi A
    Mol Divers; 2021 Aug; 25(3):1361-1373. PubMed ID: 34264440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-like molecules with anti-trypanothione synthetase activity identified by high throughput screening.
    Benítez D; Franco J; Sardi F; Leyva A; Durán R; Choi G; Yang G; Kim T; Kim N; Heo J; Kim K; Lee H; Choi I; Radu C; Shum D; No JH; Comini MA
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):912-929. PubMed ID: 35306933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Novel Chemical Scaffolds Inhibiting Trypanothione Synthetase from Pathogenic Trypanosomatids.
    Benítez D; Medeiros A; Fiestas L; Panozzo-Zenere EA; Maiwald F; Prousis KC; Roussaki M; Calogeropoulou T; Detsi A; Jaeger T; Šarlauskas J; Peterlin Mašič L; Kunick C; Labadie GR; Flohé L; Comini MA
    PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004617. PubMed ID: 27070550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical validation of trypanothione synthetase: a potential drug target for human trypanosomiasis.
    Torrie LS; Wyllie S; Spinks D; Oza SL; Thompson S; Harrison JR; Gilbert IH; Wyatt PG; Fairlamb AH; Frearson JA
    J Biol Chem; 2009 Dec; 284(52):36137-36145. PubMed ID: 19828449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and biological evaluation of Trypanosoma brucei trypanothione synthetase inhibitors.
    Spinks D; Torrie LS; Thompson S; Harrison JR; Frearson JA; Read KD; Fairlamb AH; Wyatt PG; Gilbert IH
    ChemMedChem; 2012 Jan; 7(1):95-106. PubMed ID: 22162199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of novel polyamine analogs with anti-protozoal activity by computer guided drug repositioning.
    Alberca LN; Sbaraglini ML; Balcazar D; Fraccaroli L; Carrillo C; Medeiros A; Benitez D; Comini M; Talevi A
    J Comput Aided Mol Des; 2016 Apr; 30(4):305-21. PubMed ID: 26891837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trypanothione synthetase confers growth, survival advantage and resistance to anti-protozoal drugs in Trypanosoma cruzi.
    Mesías AC; Sasoni N; Arias DG; Pérez Brandán C; Orban OCF; Kunick C; Robello C; Comini MA; Garg NJ; Zago MP
    Free Radic Biol Med; 2019 Jan; 130():23-34. PubMed ID: 30359758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and chemical analyses reveal that trypanothione synthetase but not glutathionylspermidine synthetase is essential for Leishmania infantum.
    Sousa AF; Gomes-Alves AG; Benítez D; Comini MA; Flohé L; Jaeger T; Passos J; Stuhlmann F; Tomás AM; Castro H
    Free Radic Biol Med; 2014 Aug; 73():229-38. PubMed ID: 24853758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiol redox biology of trypanosomatids and potential targets for chemotherapy.
    Leroux AE; Krauth-Siegel RL
    Mol Biochem Parasitol; 2016; 206(1-2):67-74. PubMed ID: 26592324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of novel Leishmania major trypanothione synthetase inhibitors by high-throughput screening.
    Phan TN; Park KP; Benítez D; Comini MA; Shum D; No JH
    Biochem Biophys Res Commun; 2022 Dec; 637():308-313. PubMed ID: 36413853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Buthionine sulfoximine is a multitarget inhibitor of trypanothione synthesis in Trypanosoma cruzi.
    Vázquez C; Mejia-Tlachi M; González-Chávez Z; Silva A; Rodríguez-Zavala JS; Moreno-Sánchez R; Saavedra E
    FEBS Lett; 2017 Dec; 591(23):3881-3894. PubMed ID: 29127710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural insights into the enzymes of the trypanothione pathway: targets for antileishmaniasis drugs.
    Colotti G; Baiocco P; Fiorillo A; Boffi A; Poser E; Chiaro FD; Ilari A
    Future Med Chem; 2013 Oct; 5(15):1861-75. PubMed ID: 24144416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-Substituted 3-chlorokenpaullone derivatives are potent inhibitors of Trypanosoma brucei bloodstream forms.
    Orban OC; Korn RS; Benítez D; Medeiros A; Preu L; Loaëc N; Meijer L; Koch O; Comini MA; Kunick C
    Bioorg Med Chem; 2016 Aug; 24(16):3790-800. PubMed ID: 27349574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Properties of trypanothione synthetase from Trypanosoma brucei.
    Oza SL; Ariyanayagam MR; Aitcheson N; Fairlamb AH
    Mol Biochem Parasitol; 2003 Sep; 131(1):25-33. PubMed ID: 12967709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive Predictive Value Surfaces as a Complementary Tool to Assess the Performance of Virtual Screening Methods.
    Morales JF; Chuguransky S; Alberca LN; Alice JI; Goicoechea S; Ruiz ME; Bellera CL; Talevi A
    Mini Rev Med Chem; 2020; 20(14):1447-1460. PubMed ID: 32072906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of L. infantum trypanothione synthetase inhibitors with leishmanicidal activity from a (non-biased) in-house chemical library.
    Alcón-Calderón M; de Lucio H; García-Soriano JC; Revuelto A; de Castro S; López-Gutiérrez C; San-Félix A; Quesada E; Gago F; Camarasa MJ; Jiménez-Ruiz A; Velázquez S
    Eur J Med Chem; 2022 Dec; 243():114675. PubMed ID: 36075146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissecting the essentiality of the bifunctional trypanothione synthetase-amidase in Trypanosoma brucei using chemical and genetic methods.
    Wyllie S; Oza SL; Patterson S; Spinks D; Thompson S; Fairlamb AH
    Mol Microbiol; 2009 Nov; 74(3):529-40. PubMed ID: 19558432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico identification and evaluation of new Trypanosoma cruzi trypanothione reductase (TcTR) inhibitors obtained from natural products database of the Bahia semi-arid region (NatProDB).
    da Paixão VG; Pita SSDR
    Comput Biol Chem; 2019 Apr; 79():36-47. PubMed ID: 30710804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of Trypanosoma brucei trypanothione synthetase as drug target.
    Comini MA; Guerrero SA; Haile S; Menge U; Lünsdorf H; Flohé L
    Free Radic Biol Med; 2004 May; 36(10):1289-302. PubMed ID: 15110394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cynaropicrin targets the trypanothione redox system in Trypanosoma brucei.
    Zimmermann S; Oufir M; Leroux A; Krauth-Siegel RL; Becker K; Kaiser M; Brun R; Hamburger M; Adams M
    Bioorg Med Chem; 2013 Nov; 21(22):7202-9. PubMed ID: 24080104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.